Lipoxin receptors

TheScientificWorldJournal

Volumn 7, Issue , 2007, Pages 1393-1412

  Romano, Mario ^a   Recchia, Irene ^a   Recchiuti, Antonio ^a  

^a UNIVERSITY OF CHIETI   (Italy)

Author keywords

Anti inflammatory eicosanoids; Arachidonic acid; Inflammation; Leukotriene; Lipoxin; Receptor; Signaling

Indexed keywords

ACETYLSALICYLIC ACID; ANTIINFLAMMATORY AGENT; ARACHIDONIC ACID; ASPIRIN TRIGGERED LIPOXIN; FORMYLPEPTIDE RECEPTOR LIKE 1 AGONIST; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; ISOPRENOID PHOSPHATE; LIPOXIN; LIPOXIN A; METHYLPREDNISOLONE ACEPONATE; PHOSPHOLIPASE D; PHOSPHOTRANSFERASE; SUPPRESSOR OF CYTOKINE SIGNALING 2; TRYPTOPHYLLYSYLTYROSYLMETHIONYLVALYLMETHIONINE; UNCLASSIFIED DRUG;

ANTIINFLAMMATORY ACTIVITY; BINDING AFFINITY; BIOSYNTHESIS; CALCIUM CELL LEVEL; CELL TYPE; COLITIS; DIARRHEA; ENZYME ACTIVITY; EYE INFLAMMATION; GRAFT VERSUS HOST REACTION; HUMAN; IMMUNOREGULATION; NONHUMAN; PATHOLOGY; PROTEIN EXPRESSION; PROTEIN INTERACTION; REVIEW; SIGNAL TRANSDUCTION; SKIN DEFECT; WEIGHT REDUCTION;

ARACHIDONATE 5-LIPOXYGENASE; HUMANS; LIPOXINS; PROTEIN BINDING; RECEPTORS, LIPOXIN;

EID: 34548756307     PISSN: None     EISSN: 1537744X     Source Type: Journal    
DOI: 10.1100/tsw.2007.186     Document Type: Review

References (110)

1. Fiore, S. and Serhan, C.N. (1990) Formation of lipoxins and leukotrienes during receptor-mediated interactions of human platelets and recombinant human granulocyte/macrophage colony-stimulating factor-primed neutrophils. J. Exp. Med.172, 1451-1457.
2. Romano, M. and Serhan, C.N. (1992) Lipoxin generation by permeabilized human platelets. Biochemistry 31, 8269-8277.
3. Sheppard, K.A., Greenberg, S.M., Funk, C.D., Romano, M., and Serhan, C.N. (1992) Lipoxin generation by human megakaryocyte-induced 12-lipoxygenase. Biochim. Biophys. Acta 1133, 223-234.
4. Romano, M., Chen, X.S., Takahashi, Y., Yamamoto, S., Funk, C.D., and Serhan, C.N. (1993) Lipoxin synthase activity of human platelet 12-lipoxygenase. Biochem. J. 296, 127-133.
5. Brezinski, D.A., Nesto, R.W., and Serhan, C.N. (1992) Angioplasty triggers intracoronary leukotrienes and lipoxin A4. Impact of aspirin therapy. Circulation 86, 56-63.
6. Gangemi, S., Luciotti, G., D'Urbano, E., Mallamace, A., Santoro, D., Bellinghieri, G., Davi, G., and Romano, M. (2003) Physical exercise increases urinary excretion of lipoxin A4 and related compounds. J. Appl. Physiol. 94, 2237-2240.
7. Serhan, C.N. (1997) Lipoxins and novel aspirin-triggered 15-epi-lipoxins (ATL): a jungle of cell-cell interactions or a therapeutic opportunity? Prostaglandins 53, 107-137.
8. Chavis, C., Vachier, I., Chanez, P., Bousquet, J., and Godard, P. (1996) 5(S),15(S)-dihydroxyeicosatetraenoic acid and lipoxin generation in human polymorphonuclear cells: dual specificity of 5-lipoxygenase towards endogenous and exogenous precursors. J. Exp. Med. 183, 1633-1643.
9. Serhan, C.N., Hirsch, U., Palmblad, J., and Samuelsson, B. (1987) Formation of lipoxin A by granulocytes from eosinophilic donors. FEBS Lett. 217, 242-246.
10. Levy, B.D., Romano, M., Chapman, H.A., Reilly, J.J., Drazen, J., and Serhan, C.N. (1993) Human alveolar macrophages have 15-lipoxygenase and generate 15(S)-hydroxy-5,8,11-cis-13-trans-eicosatetraenoic acid and lipoxins. J. Clin. Invest. 92, 1572-1579.
11. Lee, T.H., Crea, A.E., Gant, V., Spur, B.W., Marron, B.E., Nicolaou, K.C., Reardon, E., Brezinski, M., and Serhan, C.N. (1990) Identification of lipoxin A4 and its relationship to the sulfidopeptide leukotrienes C4, D4, and E4 in the bronchoalveolar lavage fluids obtained from patients with selected pulmonary diseases. Am. Rev. Respir. Dis. 141, 1453-1458.
12. Claria, J. and Serhan, C.N. (1995) Aspirin triggers previously undescribed bioactive eicosanoids by human endothelial cell-leukocyte interactions. Proc. Natl. Acad. Sci. U. S. A. 92, 9475-9479.
13. Titos, E., Chiang, N., Serhan, C.N., Romano, M., Gaya, J., Pueyo, G., and Claria, J. (1999) Hepatocytes are a rich source of novel aspirin-triggered 15-epi-lipoxin A(4). Am. J. Physiol. 277, C870-877.
14. Claria, J., Lee, M.H., and Serhan, C.N. (1996) Aspirin-triggered lipoxins (15-epi-LX) are generated by the human lung adenocarcinoma cell line (A549)-neutrophil interactions and are potent inhibitors of cell proliferation. Mol. Med. 2, 583-596.
15. Fiorucci, S., Santucci, L., Wallace, J.L., Sardina, M., Romano, M., del Soldato, P., and Morelli, A. (2003) Interaction of a selective cyclooxygenase-2 inhibitor with aspirin and NO-releasing aspirin in the human gastric mucosa. Proc. Natl. Acad. Sci. U. S. A. 100, 10937-10941.
16. Chiang, N., Bermudez, E.A., Ridker, P.M., Hurwitz, S., and Serhan, C.N. (2004) Aspirin triggers antiinflammatory 15-epi-lipoxin A4 and inhibits thromboxane in a randomized human trial. Proc. Natl. Acad. Sci. U. S. A. 101, 15178-15183.
17. Romano, M. (2006) Lipid mediators: lipoxin and aspirin-triggered 15-epi-lipoxins. Inflamm. Allergy. Drug Targets 5, 81-90.
18. Guilford, W.J., Bauman, J.G., Skuballa, W., Bauer, S., Wei, G.P., Davey, D., Schaefer, C., Mallari, C., Terkelsen, J., Tseng, J.L., Shen, J., Subramanyam, B., Schottelius, A.J., and Parkinson, J.F. (2004) Novel 3-oxa lipoxin A4 analogues with enhanced chemical and metabolic stability have anti-inflammatory activity in vivo. J. Med. Chem. 47, 2157-2165.
19. Romano, M. (2005) Lipoxin analogs and lipoxin formation in vivo. Prostaglandins Leukot. Essent. Fatty Acids 73, 239-243.
20. Serhan, C.N., Maddox, J.F., Petasis, N.A., Akritopoulou-Zanze, I., Papayianni, A., Brady, H.R., Colgan, S.P., and Madara, J.L. (1995) Design of lipoxin A4 stable analogs that block transmigration and adhesion of human neutrophils. Biochemistry 34, 14609-14615.
21. Hachicha, M., Pouliot, M., Petasis, N.A., and Serhan, C.N. (1999) Lipoxin (LX)A4 and aspirin-triggered 15-epi-LXA4 inhibit tumor necrosis factor 1alpha-initiated neutrophil responses and trafficking: regulators of a cytokinechemokine axis. J. Exp. Med. 189, 1923-1930.
22. Jozsef, L., Zouki, C., Petasis, N.A., Serhan, C.N., and Filep, J.G. (2002) Lipoxin A4 and aspirin-triggered 15-epilipoxin A4 inhibit peroxynitrite formation, NF-kappa B and AP-1 activation, and IL-8 gene expression in human leukocytes. Proc. Natl. Acad. Sci. U. S. A. 99, 13266-13271.
23. Fiore, S. and Serhan, C.N. (1995) Lipoxin A4 receptor activation is distinct from that of the formyl peptide receptor in myeloid cells: inhibition of CD11/18 expression by lipoxin A4-lipoxin A4 receptor interaction. Biochemistry 34, 16678-16686.
24. Gewirtz, A.T., Fokin, V.V., Petasis, N.A., Serhan, C.N., and Madara, J.L. (1999) LXA4, aspirin-triggered 15-epi-LXA4, and their analogs selectively downregulate PMN azurophilic degranulation. Am. J. Physiol. 276, C988-994.
25. Colgan, S.P., Serhan, C.N., Parkos, C.A., Delp-Archer, C., and Madara, J.L. (1993) Lipoxin A4 modulates transmigration of human neutrophils across intestinal epithelial monolayers. J. Clin. Invest. 92, 75-82.
26. Fierro, I.M., Colgan, S.P., Bernasconi, G., Petasis, N.A., Clish, C.B., Arita, M., and Serhan, C.N. (2003) Lipoxin A4 and aspirin-triggered 15-epi-lipoxin A4 inhibit human neutrophil migration: comparisons between synthetic 15 epimers in chemotaxis and transmigration with microvessel endothelial cells and epithelial cells. J. Immunol. 170, 2688-2694.
27. Maddox, J.F. and Serhan, C.N. (1996) Lipoxin A4 and B4 are potent stimuli for human monocyte migration and adhesion: selective inactivation by dehydrogenation and reduction. J. Exp. Med. 183, 137-146.
28. Romano, M., Maddox, J.F., and Serhan, C.N. (1996) Activation of human monocytes and the acute monocytic leukemia cell line (THP-1) by lipoxins involves unique signaling pathways for lipoxin A4 versus lipoxin B4: evidence for differential Ca2+ mobilization. J. Immunol. 157, 2149-2154.
29. Godson, C., Mitchell, S., Harvey, K., Petasis, N.A., Hogg, N., and Brady, H.R. (2000) Cutting edge: lipoxins rapidly stimulate nonphlogistic phagocytosis of apoptotic neutrophils by monocyte-derived macrophages. J. Immunol.164, 1663-1667.
30. Ramstedt, U., Serhan, C.N., Nicolaou, K.C., Webber, S.E., Wigzell, H., and Samuelsson, B. (1987) Lipoxin A-induced inhibition of human natural killer cell cytotoxicity: studies on stereospecificity of inhibition and mode of action. J. Immunol. 138, 266-270.
31. Ariel, A., Chiang, N., Arita, M., Petasis, N.A., and Serhan, C.N. (2003) Aspirin-triggered lipoxin A4 and B4 analogs block extracellular signal-regulated kinase-dependent TNF-alpha secretion from human T cells. J. Immunol. 170, 6266-6272.
32. Aliberti, J., Hieny, S., Reis e Sousa, C., Serhan, C.N., and Sher, A. (2002) Lipoxin-mediated inhibition of IL-12 production by DCs: a mechanism for regulation of microbial immunity. Nat. Immunol. 3, 76-82.
33. Machado, F.S., Johndrow, J.E., Esper, L., Dias, A., Bafica, A., Serhan, C.N., and Aliberti, J. (2006) Anti-inflammatory actions of lipoxin A4 and aspirin-triggered lipoxin are SOCS-2 dependent. Nat. Med. 12, 330-334.
34. Soyombo, O., Spur, B.W., and Lee, T.H. (1994) Effects of lipoxin A4 on chemotaxis and degranulation of human eosinophils stimulated by platelet-activating factor and N-formyl-L-methionyl-L-leucyl-L-phenylalanine. Allergy 49, 230-234.
35. Bandeira-Melo, C., Bozza, P.T., Diaz, B.L., Cordeiro, R.S., Jose, P.J., Martins, M.A., and Serhan, C.N. (2000) Cutting edge: lipoxin (LX) A4 and aspirin-triggered 15-epi-LXA4 block allergen-induced eosinophil trafficking. J. Immunol. 164, 2267-2271.
36. Scalia, R., Gefen, J., Petasis, N.A., Serhan, C.N., and Lefer, A.M. (1997) Lipoxin A4 stable analogs inhibit leukocyte rolling and adherence in the rat mesenteric microvasculature: role of P-selectin. Proc. Natl. Acad. Sci. U. S. A. 94, 9967-9972.
37. Nascimento-Silva, V., Arruda, M.A., Barja-Fidalgo, C., Villela, C.G., and Fierro, I.M. (2005) Novel lipid mediator aspirin-triggered lipoxin A4 induces heme oxygenase-1 in endothelial cells. Am. J. Physiol. Cell. Physiol. 289, C557-563.
38. Biteman, B., Hassan, I.R., Walker, E., Leedom, A.J., Dunn, M., Seta, F., Laniado-Schawartzman, M., and Gronert, K. (2007) Interdependence of lipoxin A4 and heme-oxygenase in counter-regulating inflammation during corneal wound healing. FASEB J. 21(9), 2257-2266.
39. Sodin-Semrl, S., Taddeo, B., Tseng, D., Varga, J., and Fiore, S. (2000) Lipoxin A4 inhibits IL-1 beta-induced IL-6, IL-8, and matrix metalloproteinase-3 production in human synovial fibroblasts and enhances synthesis of tissue inhibitors of metalloproteinases. J. Immunol. 164, 2660-2666.
40. Planaguma, A., Titos, E., Lopez-Parra, M., Gaya, J., Pueyo, G., Arroyo, V., and Claria, J. (2002) Aspirin (ASA) regulates 5-lipoxygenase activity and peroxisome proliferator-activated receptor alpha-mediated CINC-1 release in rat liver cells: novel actions of lipoxin A4 (LXA4) and ASA-triggered 15-epi-LXA4. FASEB J. 16, 1937-1939.
41. Karp, C.L., Flick, L.M., Park, K.W., Softic, S., Greer, T.M., Keledjian, R., Yang, R., Uddin, J., Guggino, W.B., Atabani, S.F., Belkaid, Y., Xu, Y., Whitsett, J.A., Accurso, F.J., Wills-Karp, M., and Petasis, N.A. (2004) Defective lipoxin-mediated anti-inflammatory activity in the cystic fibrosis airway. Nat. Immunol. 5, 388-392.
42. Bonnans, C., Fukunaga, K., Levy, M.A., and Levy, B.D. (2006) Lipoxin A(4) regulates bronchial epithelial cell responses to acid injury. Am. J. Pathol. 168, 1064-1072.
43. Levy, B.D., De Sanctis, G.T., Devchand, P.R., Kim, E., Ackerman, K., Schmidt, B.A., Szczeklik, W., Drazen, J.M., and Serhan, C.N. (2002) Multi-pronged inhibition of airway hyper-responsiveness and inflammation by lipoxin A(4). Nat. Med. 8, 1018-1023.
44. Fiorucci, S., de Lima, O.M., Jr., Mencarelli, A., Palazzetti, B., Distrutti, E., McKnight, W., Dicay, M., Ma, L., Romano, M., Morelli, A., and Wallace, J.L. (2002) Cyclooxygenase-2-derived lipoxin A4 increases gastric resistance to aspirin-induced damage. Gastroenterology 123, 1598-1606.
45. Chiang, N., Takano, T., Arita, M., Watanabe, S., and Serhan, C.N. (2003) A novel rat lipoxin A4 receptor that is conserved in structure and function. Br. J. Pharmacol. 139, 89-98.
46. Fiorucci, S., Wallace, J.L., Mencarelli, A., Distrutti, E., Rizzo, G., Farneti, S., Morelli, A., Tseng, J.L., Suramanyam, B., Guilford, W.J., and Parkinson, J.F. (2004) A beta-oxidation-resistant lipoxin A4 analog treats hapten-induced colitis by attenuating inflammation and immune dysfunction. Proc. Natl. Acad. Sci. U. S. A. 101, 15736-15741.
47. Gewirtz, A.T., Collier-Hyams, L.S., Young, A.N., Kucharzik, T., Guilford, W.J., Parkinson, J.F., Williams, I.R., Neish, A.S., and Madara, J.L. (2002) Lipoxin a4 analogs attenuate induction of intestinal epithelial proinflammatory gene expression and reduce the severity of dextran sodium sulfate-induced colitis. J. Immunol. 168, 5260-5267.
48. Serhan, C.N., Jain, A., Marleau, S., Clish, C., Kantarci, A., Behbehani, B., Colgan, S.P., Stahl, G.L., Merched, A., Petasis, N.A., Chan, L., and Van Dyke, T.E. (2003) Reduced inflammation and tissue damage in transgenic rabbits overexpressing 15-lipoxygenase and endogenous anti-inflammatory lipid mediators. J. Immunol. 171, 6856-6865.
49. Schottelius, A.J., Giesen, C., Asadullah, K., Fierro, I.M., Colgan, S.P., Bauman, J., Guilford, W., Perez, H.D., and Parkinson, J.F. (2002) An aspirin-triggered lipoxin A4 stable analog displays a unique topical anti-inflammatory profile. J. Immunol. 169, 7063-7070.
50. Gronert, K. (2005) Lipoxins in the eye and their role in wound healing. Prostaglandins Leukot. Essent. Fatty Acids 73, 221-229.
51. Devchand, P.R., Schmidt, B.A., Primo, V.C., Zhang, Q.Y., Arnaout, M.A., Serhan, C.N., and Nikolic, B. (2005) A synthetic eicosanoid LX-mimetic unravels host-donor interactions in allogeneic BMT-induced GvHD to reveal an early protective role for host neutrophils. FASEB J. 19, 203-210.
52. Fiore, S., Ryeom, S.W., Weller, P.F., and Serhan, C.N. (1992) Lipoxin recognition sites. Specific binding of labeled lipoxin A4 with human neutrophils. J. Biol. Chem. 267, 16168-16176.
53. Fiore, S., Romano, M., Reardon, E.M., and Serhan, C.N. (1993) Induction of functional lipoxin A4 receptors in HL-60 cells. Blood 81, 3395-3403.
54. Gronert, K., Martinsson-Niskanen, T., Ravasi, S., Chiang, N., and Serhan, C.N. (2001) Selectivity of recombinant human leukotriene D(4), leukotriene B(4), and lipoxin A(4) receptors with aspirin-triggered 15-epi-LXA(4) and regulation of vascular and inflammatory responses. Am. J. Pathol. 158, 3-9.
55. Fiore, S., Maddox, J.F., Perez, H.D., and Serhan, C.N. (1994) Identification of a human cDNA encoding a functional high affinity lipoxin A4 receptor. J. Exp. Med. 180, 253-260.
56. Murphy, P.M., Ozcelik, T., Kenney, R.T., Tiffany, H.L., McDermott, D., and Francke, U. (1992) A structural homologue of the N-formyl peptide receptor. Characterization and chromosome mapping of a peptide chemoattractant receptor family. J. Biol. Chem. 267, 7637-7643.
57. Bao, L., Gerard, N.P., Eddy, R.L., Jr., Shows, T.B., and Gerard, C. (1992) Mapping of genes for the human C5a receptor (C5AR), human FMLP receptor (FPR), and two FMLP receptor homologue orphan receptors (FPRH1, FPRH2) to chromosome 19. Genomics 13, 437-440.
58. Ye, R.D., Cavanagh, S.L., Quehenberger, O., Prossnitz, E.R., and Cochrane, C.G. (1992) Isolation of a cDNA that encodes a novel granulocyte N-formyl peptide receptor. Biochem. Biophys. Res. Commun. 184, 582-589.
59. Perez, H.D., Holmes, R., Kelly, E., McClary, J., and Andrews, W.H. (1992) Cloning of a cDNA encoding a receptor related to the formyl peptide receptor of human neutrophils. Gene 118, 303-304.
60. Nomura, H., Nielsen, B.W., and Matsushima, K. (1993) Molecular cloning of cDNAs encoding a LD78 receptor and putative leukocyte chemotactic peptide receptors. Int. Immunol.5, 1239-1249.
61. Brink, C., Dahlen, S.E., Drazen, J., Evans, J.F., Hay, D.W., Nicosia, S., Serhan, C.N., Shimizu, T., and Yokomizo, T. (2003) International Union of Pharmacology XXXVII. Nomenclature for leukotriene and lipoxin receptors. Pharmacol. Rev. 55, 195-227.
62. Chiang, N., Serhan, C.N., Dahlen, S.E., Drazen, J.M., Hay, D.W., Rovati, G.E., Shimizu, T., Yokomizo, T., and Brink, C. (2006) The lipoxin receptor ALX: potent ligand-specific and stereoselective actions in vivo. Pharmacol. Rev. 58, 463-487.
63. Sahagun-Ruiz, A., Colla, J.S., Juhn, J., Gao, J.L., Murphy, P.M., and McDermott, D.H. (2001) Contrasting evolution of the human leukocyte N-formylpeptide receptor subtypes FPR and FPRL1R. Genes Immun. 2, 335-342.
64. Takano, T., Fiore, S., Maddox, J.F., Brady, H.R., Petasis, N.A., and Serhan, C.N. (1997) Aspirin-triggered 15-epilipoxin A4 (LXA4) and LXA4 stable analogues are potent inhibitors of acute inflammation: evidence for antiinflammatory receptors. J. Exp. Med. 185, 1693-1704.
65. Gao, J.L., Chen, H., Filie, J.D., Kozak, C.A., and Murphy, P.M. (1998) Differential expansion of the N-formylpeptide receptor gene cluster in human and mouse. Genomics 51, 270-276.
66. Vaughn, M.W., Proske, R.J., and Haviland, D.L. (2002) Identification, cloning, and functional characterization of a murine lipoxin A4 receptor homologue gene. J. Immunol. 169, 3363-3369.
67. Devchand, P.R., Arita, M., Hong, S., Bannenberg, G., Moussignac, R.L., Gronert, K., and Serhan, C.N. (2003) Human ALX receptor regulates neutrophil recruitment in transgenic mice: roles in inflammation and host defense. FASEB J. 17, 652-659.
68. Kang, Y., Taddeo, B., Varai, G., Varga, J., and Fiore, S. (2000) Mutations of serine 236-237 and tyrosine 302 residues in the human lipoxin A4 receptor intracellular domains result in sustained signaling. Biochemistry 39, 13551-13557.
69. Chiang, N., Fierro, I.M., Gronert, K., and Serhan, C.N. (2000) Activation of lipoxin A(4) receptors by aspirin-triggered lipoxins and select peptides evokes ligand-specific responses in inflammation. J. Exp. Med. 191, 1197-1208.
70. Le, Y., Ye, R.D., Gong, W., Li, J., Iribarren, P., and Wang, J.M. (2005) Identification of functional domains in the formyl peptide receptor-like 1 for agonist-induced cell chemotaxis. FEBS J. 272, 769-778.
71. Maddox, J.F., Hachicha, M., Takano, T., Petasis, N.A., Fokin, V.V., and Serhan, C.N. (1997) Lipoxin A4 stable analogs are potent mimetics that stimulate human monocytes and THP-1 cells via a G-protein-linked lipoxin A4 receptor. J. Biol. Chem. 272, 6972-6978.
72. de Paulis, A., Montuori, N., Prevete, N., Fiorentino, I., Rossi, F.W., Visconte, V., Rossi, G., Marone, G., and Ragno, P. (2004) Urokinase induces basophil chemotaxis through a urokinase receptor epitope that is an endogenous ligand for formyl peptide receptor-like 1 and -like 2. J. Immunol. 173, 5739-5748.
73. Yang, D., Chen, Q., Le, Y., Wang, J.M., and Oppenheim, J.J. (2001) Differential regulation of formyl peptide receptor-like 1 expression during the differentiation of monocytes to dendritic cells and macrophages. J. Immunol. 166, 4092-4098.
74. Gronert, K., Gewirtz, A., Madara, J.L., and Serhan, C.N. (1998) Identification of a human enterocyte lipoxin A4 receptor that is regulated by interleukin (IL)-13 and interferon gamma and inhibits tumor necrosis factor alpha-induced IL-8 release. J. Exp. Med. 187, 1285-1294.
75. Le, Y., Hu, J., Gong, W., Shen, W., Li, B., Dunlop, N.M., Halverson, D.O., Blair, D.G., and Wang, J.M. (2000) Expression of functional formyl peptide receptors by human astrocytoma cell lines. J. Neuroimmunol. 111, 102-108.
76. Ying, G., Iribarren, P., Zhou, Y., Gong, W., Zhang, N., Yu, Z.X., Le, Y., Cui, Y., and Wang, J.M. (2004) Humanin, a newly identified neuroprotective factor, uses the G protein-coupled formylpeptide receptor-like-1 as a functional receptor. J. Immunol. 172, 7078-7085.
77. Koczulla, R., von Degenfeld, G., Kupatt, C., Krotz, F., Zahler, S., Gloe, T., Issbrucker, K., Unterberger, P., Zaiou, M., Lebherz, C., Karl, A., Raake, P., Pfosser, A., Boekstegers, P., Welsch, U., Hiemstra, P.S., Vogelmeier, C., Gallo, R.L., Clauss, M., and Bals, R. (2003) An angiogenic role for the human peptide antibiotic LL-37/hCAP-18. J. Clin. Invest. 111, 1665-1672.
78. Perretti, M., Chiang, N., La, M., Fierro, I.M., Marullo, S., Getting, S.J., Solito, E., and Serhan, C.N. (2002) Endogenous lipid- and peptide-derived anti-inflammatory pathways generated with glucocorticoid and aspirin treatment activate the lipoxin A4 receptor. Nat. Med. 8, 1296-1302.
79. Scannell, M., Flanagan, M.B., deStefani, A., Wynne, K.J., Cagney, G., Godson, C., and Maderna, P. (2007) Annexin-1 and peptide derivatives are released by apoptotic cells and stimulate phagocytosis of apoptotic neutrophils by macrophages. J. Immunol. 178, 4595-4605.
80. Blasi, F. (1997) uPA, uPAR, PAI-1: key intersection of proteolytic, adhesive and chemotactic highways? Immunol. Today. 18, 415-417.
81. Mondino, A. and Blasi, F. (2004) uPA and uPAR in fibrinolysis, immunity and pathology. Trends Immunol. 25, 450-455.
82. Resnati, M., Pallavicini, I., Wang, J.M., Oppenheim, J., Serhan, C.N., Romano, M., and Blasi, F. (2002) The fibrinolytic receptor for urokinase activates the G protein-coupled chemotactic receptor FPRL1/LXA4R. Proc. Natl. Acad. Sci. U. S. A. 99, 1359-1364.
83. Mazzieri, R., D'Alessio, S., Kenmoe, R.K., Ossowski, L., and Blasi, F. (2006) An uncleavable uPAR mutant allows dissection of signaling pathways in uPA-dependent cell migration. Mol. Biol. Cell 17, 367-378.
84. Stone, M.J. (1990) Amyloidosis: a final common pathway for protein deposition in tissues. Blood 75, 531-545.
85. Su, S.B., Gong, W., Gao, J.L., Shen, W., Murphy, P.M., Oppenheim, J.J., and Wang, J.M. (1999) A seven-transmembrane, G protein-coupled receptor, FPRL1, mediates the chemotactic activity of serum amyloid A for human phagocytic cells. J. Exp. Med. 189, 395-402.
86. He, R., Sang, H., and Ye, R.D. (2003) Serum amyloid A induces IL-8 secretion through a G protein-coupled receptor, FPRL1/LXA4R. Blood 101, 1572-1581.
87. Tiffany, H.L., Lavigne, M.C., Cui, Y.H., Wang, J.M., Leto, T.L., Gao, J.L., and Murphy, P.M. (2001) Amyloid-beta induces chemotaxis and oxidant stress by acting at formylpeptide receptor 2, a G protein-coupled receptor expressed in phagocytes and brain. J. Biol. Chem. 276, 23645-23652.
88. Yazawa, H., Yu, Z.X., Takeda, Le, Y., Gong, W., Ferrans, V.J., Oppenheim, J.J., Li, C.C., and Wang, J.M. (2001) Beta amyloid peptide (Abeta42) is internalized via the G-protein-coupled receptor FPRL1 and forms fibrillar aggregates in macrophages. FASEB J. 15, 2454-2462.
89. Peyrin, J.M., Lasmezas, C.I., Haik, S., Tagliavini, F., Salmona, M., Williams, A., Richie, D., Deslys, J.P., and Dormont, D. (1999) Microglial cells respond to amyloidogenic PrP peptide by the production of inflammatory cytokines. Neuroreport 10, 723-729.
90. Le, Y., Yazawa, H., Gong, W., Yu, Z., Ferrans, V.J., Murphy, P.M., and Wang, J.M. (2001) The neurotoxic prion peptide fragment PrP(106-126) is a chemotactic agonist for the G protein-coupled receptor formyl peptide receptor-like 1. J. Immunol. 166, 1448-1451.
91. Hashimoto, Y., Niikura, T., Tajima, H., Yasukawa, T., Sudo, H., Ito, Y., Kita, Y., Kawasumi, M., Kouyama, K., Doyu, M., Sobue, G., Koide, T., Tsuji, S., Lang, J., Kurokawa, K., and Nishimoto, I. (2001) A rescue factor abolishing neuronal cell death by a wide spectrum of familial Alzheimer's disease genes and Abeta. Proc. Natl. Acad. Sci. U. S. A. 98, 6336-6341.
92. Mitchell, S., Thomas, G., Harvey, K., Cottell, D., Reville, K., Berlasconi, G., Petasis, N.A., Erwig, L., Rees, A.J., Savill, J., Brady, H.R., and Godson, C. (2002) Lipoxins, aspirin-triggered epi-lipoxins, lipoxin stable analogues, and the resolution of inflammation: stimulation of macrophage phagocytosis of apoptotic neutrophils in vivo. J. Am. Soc. Nephrol. 13, 2497-2507.
93. Fierro, I.M., Kutok, J.L., and Serhan, C.N. (2002) Novel lipid mediator regulators of endothelial cell proliferation and migration: aspirin-triggered- 15R-lipoxin A(4) and lipoxin A(4). J. Pharmacol. Exp. Ther. 300, 385-392.
94. Elagoz, A., Henderson, D., Babu, P.S., Salter, S., Grahames, C., Bowers, L., Roy, M.O., Laplante, P., Grazzini, E., Ahmad, S., and Lembo, P.M. (2004) A truncated form of CKbeta8-1 is a potent agonist for human formyl peptide-receptor-like 1 receptor. Br. J. Pharmacol. 141, 37-46.
95. Chen, Q., Wade, D., Kurosaka, K., Wang, Z.Y., Oppenheim, J.J., and Yang, D. (2004) Temporin A and related frog antimicrobial peptides use formyl peptide receptor-like 1 as a receptor to chemoattract phagocytes. J. Immunol. 173, 2652-2659.
96. Le, Y., Murphy, P.M., and Wang, J.M. (2002) Formyl-peptide receptors revisited. Trends Immunol. 23, 541-548.
97. Fu, H., Karlsson, J., Bylund, J., Movitz, C., Karlsson, A., and Dahlgren, C. (2006) Ligand recognition and activation of formyl peptide receptors in neutrophils. J. Leukoc. Biol. 79, 247-256.
98. Bae, Y.S., Lee, H.Y., Jo, E.J., Kim, J.I., Kang, H.K., Ye, R.D., Kwak, J.Y., and Ryu, S.H. (2004) Identification of peptides that antagonize formyl peptide receptor-like 1-mediated signaling. J. Immunol. 173, 607-614.
99. Burli, R.W., Xu, H., Zou, X., Muller, K., Golden, J., Frohn, M., Adlam, M., Plant, M.H., Wong, M., McElvain, M., Regal, K., Viswanadhan, V.N., Tagari, and P., Hungate, R. (2006) Potent hFPRL1 (ALXR) agonists as potential anti-inflammatory agents. Bioorg. Med. Chem. Lett. 16, 3713-3718.
100. Bonnans, C., Mainprice, B., Chanez, P., Bousquet, J., and Urbach, V. (2003) Lipoxin A4 stimulates a cytosolic Ca2+ increase in human bronchial epithelium. J. Biol. Chem. 278, 10879-10884.
101. Bae, Y.S., Park, J.C., He, R., Ye, R.D., Kwak, J.Y., Suh, P.G., and Ho Ryu, S. (2003) Differential signaling of formyl peptide receptor-like 1 by Trp-Lys-Tyr-Met-Val-Met-CONH2 or lipoxin A4 in human neutrophils. Mol. Pharmacol. 64, 721-730.
102. Levy, B.D., Fokin, V.V., Clark, J.M., Wakelam, M.J., Petasis, N.A., and Serhan, C.N. (1999) Polyisoprenyl phosphate (PIPP) signaling regulates phospholipase D activity: a 'stop' signaling switch for aspirin-triggered lipoxin A4. FASEB J. 13, 903-911.
103. Kim, Y., Lee, B.D., Kim, O., Bae, Y.S., Lee, T., Suh, P.G., and Ryu, S.H. (2006) Pituitary adenylate cyclase-activating polypeptide 27 is a functional ligand for formyl peptide receptor-like 1. J. Immunol. 176, 2969-2975.
104. Wu, S.H., Wu, X.H., Lu, C., Dong, L., and Chen, Z.Q. (2006) Lipoxin A4 inhibits proliferation of human lung fibroblasts induced by connective tissue growth factor. Am. J. Respir. Cell Mol. Biol. 34, 65-72.
105. Maderna, P., Cottell, D.C., Berlasconi, G., Petasis, N.A., Brady, H.R., and Godson, C. (2002) Lipoxins induce actin reorganization in monocytes and macrophages but not in neutrophils: differential involvement of rho GTPases. Am. J. Pathol. 160, 2275-2283.
106. Cezar-de-Mello, P.F., Nascimento-Silva, V., Villela, C.G., and Fierro, I.M. (2006) Aspirin-triggered Lipoxin A4 inhibition of VEGF-induced endothelial cell migration involves actin polymerization and focal adhesion assembly. Oncogene 25, 122-129.
107. Sodin-Semrl, S., Spagnolo, A., Mikus, R., Barbaro, B., Varga, J., and Fiore, S. (2004) Opposing regulation of interleukin-8 and NF-kappaB responses by lipoxin A4 and serum amyloid A via the common lipoxin A receptor. Int. J. Immunopathol. Pharmacol. 17, 145-156.
108. Schaldach, C.M., Riby, J., and Bjeldanes, L.F. (1999) Lipoxin A4: a new class of ligand for the Ah receptor. Biochemistry 38, 7594-7600.
109. Badr, K.F., DeBoer, D.K., Schwartzberg, M., and Serhan, C.N. (1989) Lipoxin A4 antagonizes cellular and in vivo actions of leukotriene D4 in rat glomerular mesangial cells: evidence for competition at a common receptor. Proc. Natl. Acad. Sci. U. S. A. 86, 3438-3442.
110. McMahon, B., Stenson, C., McPhillips, F., Fanning, A., Brady, H.R., and Godson, C. (2000) Lipoxin A4 antagonizes the mitogenic effects of leukotriene D4 in human renal mesangial cells. Differential activation of MAP kinases through distinct receptors. J. Biol. Chem. 275, 27566-27575.